MARKET

SPNE

SPNE

SeaSpine Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

20.30
+1.03
+5.35%
Closed 16:00 02/24 EST
OPEN
19.10
PREV CLOSE
19.27
HIGH
20.54
LOW
19.10
VOLUME
104.47K
TURNOVER
--
52 WEEK HIGH
20.54
52 WEEK LOW
4.020
MARKET CAP
560.95M
P/E (TTM)
-12.1783
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Biological Bone Repair Materials Market Size Research Report 2021 by Growth Rate, Revenue Estimates, Market Dynamics, Industry Trends and Forecast to 2027 Says Absolute Reports
Feb 24, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Biological Bone Repair Materials Market”...
The Express Wire · 1d ago
SeaSpine to Report Fourth Quarter 2020 Financial Results on March 1, 2021
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release fourth quarter f...
GlobeNewswire · 2d ago
SeaSpine Announces Limited Commercial Launch Of WaveForm TA 3D-Printed Interbody System
SeaSpine Announces Limited Commercial Launch of WaveForm™ TA (TLIF Articulating) 3D-Printed Interbody System CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a
Benzinga · 3d ago
SeaSpine Announces Limited Commercial Launch of WaveForm(TM) TA (TLIF Articulating) 3D-Printed Interbody System
CARLSBAD, Calif., Feb 22, 2021 (GLOBE NEWSWIRE via COMTEX) -- CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:...
GlobeNewswire · 3d ago
Will SeaSpine Holdings (SPNE) Report Negative Q4 Earnings? What You Should Know
Zacks.com · 02/17 17:31
Spinal Surgery Devices Market Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2025
Japan, Japan, Wed, 17 Feb 2021 00:06:49 / Comserve Inc. / -- The report analyzes the international markets including development trends, competitive...
Comserve · 02/17 05:08
Global Orthobiologics Market Share 2021: Covid-19 Impact Analysis Report By Industry Share, Size, Key Manufacturers, Growth Factors, Regional, and Competitive Landscape to 2026
Feb 14, 2021 (The Expresswire) -- The global “Orthobiologics market” research report focuses on the confined major statistical overview for the...
The Express Wire · 02/15 04:06
Spinal Implant and Devices Market 2027 | Trends, Growth Overview, Development Size and Revenue Forecast | ARC
pune, India, Tue, 09 Feb 2021 04:47:03 / Comserve Inc. / -- The market for spinal implant and devices is expected to grow at a CAGR of around 5.6% from 2020...
Comserve · 02/09 09:49
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SPNE. Analyze the recent business situations of SeaSpine Hldg through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SPNE stock price target is 20.78 with a high estimate of 23.25 and a low estimate of 15.00.
EPS
Institutional Holdings
Institutions: 152
Institutional Holdings: 21.63M
% Owned: 78.26%
Shares Outstanding: 27.63M
TypeInstitutionsShares
Increased
42
989.30K
New
17
-410.47K
Decreased
24
660.34K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.93%
Healthcare Equipment & Supplies
+0.66%
Key Executives
Non-Executive Chairman/Independent Director
Kirtley Stephenson
President/Chief Executive Officer/Director
Keith Valentine
Chief Financial Officer/Senior Vice President/Treasurer
John Bostjancic
Senior Vice President
Dennis Cirino
Senior Vice President
Tyler Lipschultz
Vice President/General Counsel/Secretary
Patrick Keran
Vice President/Director of Sales
John Winge
Lead Director/Independent Director
Stuart Essig
Independent Director
Keith Bradley
Independent Director
Kimberly Commins-Tzoumakas
Independent Director
Michael Fekete
Independent Director
Renee Gaeta
Independent Director
Kim Commins-Tzoumakas
Independent Director
John Henneman
  • Dividends
  • Splits
  • Insider Activity
No Data
About SPNE
SeaSpine Holdings Corporation is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company offers a portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. Its spinal implants portfolio consists of a line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Orthobiologics products are used in orthopedic and dental procedures and consist of a range of bone graft substitutes to address the key elements of bone regeneration -osteoinduction, osteoconduction and osteogenesis. Spinal implant portfolio consists of a line of products for spinal decompression alignment and stabilization.

Webull offers kinds of SeaSpine Holdings Corp stock information, including NASDAQ:SPNE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPNE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SPNE stock methods without spending real money on the virtual paper trading platform.